A new 🌟 TARPSWG achievement: solid data on the largest series of WDLPS #retroperitoneal #sarcoma : after Neoadjuvant RT significantly reduced local recurrence rate Vs surgery alone. #STRASS and #STREXIT data are now corroborated. Great job Mark Fairweather! #SSO2024 #plenary

TARPSWG semiannual meeting at Society of Surgical Oncology in Atlanta. Thks to our local host Ken Cardona . Lots of discussions around new ideas, studies, projects, educational initiatives to advance the knowledge of this difficult disease.

It is a great pleasure to share the first publication of our #sarcoma group within LACOG - Latin American Cooperative Oncology Group, discussing challenges and opportunities for sarcoma care and research in Latin America.

Hope you enjoy the read, let's work to change the paradigm in Fig 2!

thelancet.com/journals/lanam…

Christmas dinner of the Sarcoma service Chirurgia dei Sarcomi INT version 3.0 of Istituto Tumori : wonderful group of surgeons, nurses, case managers, clinical trial coordinators, secretaries all dedicate to research and cure of #sarcoma #GIST #desmoid . 21 beds, 4 operations suits per week 1/4

1500 new patients per year seen in consultation, 3500 follow up visit, 450 new sarcoma/GIST/desmoid patients managed each year (>1/10 of the incidence patients in Italy), a few millions € of grants for research, over 10 clinical studies open to recruitment or follow up. 3/4

6 full time surgeons, 1 case manager, 2 clinical trial coordinators, 24 nurses, 4 secretaries, 1 surgeon scientist, 8 residents in general surgery. All together in the largest single institution service dedicated to surgery for sarcomas and GIST worldwide 2/4

An absolute pleasure to attend a reception at 10 Downing Street this evening, after our research was nominated as sarcoma research of the year. I met the most important guy in the UK Larry the Cat thanks Sarcoma UK

CR Chandrasekar Roberto Pestana, MD Anant Desai Dario Callegaro Pawel Sobczuk sylvie bonvalot It’s important to not use a ‘sarcoma mdt’ as a smokescreen. Fabio Tirotta showed that not all MDTs are the same and for patients requiring complex surgery, care in a high volume centre is critical for optimal perioperarive and long term cancer specific outcomes.

High-volume specialist centres are the way forward!

It’s time to improve patients’ care! TARPSWG Sarcoma UK SPAGN Sarcoma Alliance British Sarcoma Group NIHR Research SARCOMA CONNECT NHS England NHS England Digital Society of Surgical Oncology European Society of Surgical Oncology (ESSO) ESMO - Eur. Oncology ASCO BBC News (UK) Steve Barclay The Guardian

2) Published in BJS shows that inter-centre agreement across RPS MDTs in GB was low. Around 60% of pts in the study could either have been deemed resectable or unresectable depending on the centre they had attended.
doi.org/10.1093/bjs/zn…

1) Published in #EJC (EORTC ) shows that high-volume specialist centres (>24 cases yr) are an independent predictor of survival. 5-yr OS = 42% in non-specialist centres vs 51.7% in low-volume specialist centres and 62.8% in high-volume specialist centres
doi.org/10.1016/j.ejca…

Two important retroperitoneal #sarcoma papers both presented at CTOS are finally out!

SI on RETROPERITONEAL SARCOMA

Current management of benign retroperitoneal tumors

Fabio Tirotta Andrea Napolitano Erika Schmitz Carolyn Nessim MD Radiology of USC Jason Sicklick mylessmith CTOS TARPSWG European Society of Surgical Oncology (ESSO)

#SurgOnc #Sarcoma #SoMe4Surgery

bit.ly/3qHtuZA

June comes with the European Journal of Surgical Oncology Special Issue on RETROPERITONEAL SARCOMA edited by sylvie bonvalot
& Piotr Rutkowski!

digital flipbook 📖 ➡️ bit.ly/43GqBXA
website ➡️bit.ly/3NgL5zk

Sarcoma Alliance SARCOMA CONNECT SARC Sarcoma Cancer Care Foundation European Society of Surgical Oncology (ESSO) BASO~The Association for Cancer Surgery

TARPSWG traditional photo at the end of another successful meeting. Lots of stuff going on! Chandrajit Raut Christina Roland, MD, MS Ken Cardona Jason Sicklick Marco Fiore, MD, FACS, FEBSh Dario Callegaro Emily Keung, MD Winan van Houdt John E. Mullinax, MD, FACS @jeffreyfarma Gladdy Lab Dirk Strauss CTOS Society of Surgical Oncology